These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1239 related items for PubMed ID: 18004186
1. Daily stress and gastrointestinal symptoms in women with irritable bowel syndrome. Hertig VL, Cain KC, Jarrett ME, Burr RL, Heitkemper MM. Nurs Res; 2007; 56(6):399-406. PubMed ID: 18004186 [Abstract] [Full Text] [Related]
2. Psychological distress and GI symptoms are related to severity of bloating in women with irritable bowel syndrome. Park HJ, Jarrett M, Cain K, Heitkemper M. Res Nurs Health; 2008 Apr; 31(2):98-107. PubMed ID: 18181134 [Abstract] [Full Text] [Related]
8. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Paré P, Gray J, Lam S, Balshaw R, Khorasheh S, Barbeau M, Kelly S, McBurney CR. Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129 [Abstract] [Full Text] [Related]
9. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment. Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA. Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206 [Abstract] [Full Text] [Related]
10. Symptoms across the menstrual cycle in women with irritable bowel syndrome. Heitkemper MM, Cain KC, Jarrett ME, Burr RL, Hertig V, Bond EF. Am J Gastroenterol; 2003 Feb; 98(2):420-30. PubMed ID: 12591063 [Abstract] [Full Text] [Related]
13. Treatment of irritable bowel syndrome. A case control experience. Astegiano M, Pellicano R, Terzi E, Simondi D, Rizzetto M. Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865 [Abstract] [Full Text] [Related]
14. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. Katsinelos P, Lazaraki G, Kountouras J, Paroutoglou G, Oikonomidou I, Mimidis K, Koutras C, Gelas G, Tziomalos K, Zavos C, Pilpilidis I, Chatzimavroudis G. Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207 [Abstract] [Full Text] [Related]
16. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? Sach J, Bolus R, Fitzgerald L, Naliboff BD, Chang L, Mayer EA. Am J Gastroenterol; 2002 Dec; 97(12):3131-8. PubMed ID: 12492200 [Abstract] [Full Text] [Related]
17. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials. Rahimi R, Nikfar S, Abdollahi M. Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935 [Abstract] [Full Text] [Related]
18. The role of stress in symptom exacerbation among IBS patients. Blanchard EB, Lackner JM, Jaccard J, Rowell D, Carosella AM, Powell C, Sanders K, Krasner S, Kuhn E. J Psychosom Res; 2008 Feb; 64(2):119-28. PubMed ID: 18222125 [Abstract] [Full Text] [Related]
19. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS. Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG. Am J Gastroenterol; 2007 Aug; 102(8):1709-19. PubMed ID: 17509028 [Abstract] [Full Text] [Related]
20. Irritable bowel syndrome: a population based study. Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A, Habibi M, Zali MR. J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812 [Abstract] [Full Text] [Related] Page: [Next] [New Search]